HUE055259T2 - (1R,3S)-3-(5-ciano-4-fenil-1,3-tiazol-2-il-karbamoil)ciklopentánkarbonsav aminsója - Google Patents

(1R,3S)-3-(5-ciano-4-fenil-1,3-tiazol-2-il-karbamoil)ciklopentánkarbonsav aminsója

Info

Publication number
HUE055259T2
HUE055259T2 HUE18710011A HUE18710011A HUE055259T2 HU E055259 T2 HUE055259 T2 HU E055259T2 HU E18710011 A HUE18710011 A HU E18710011A HU E18710011 A HUE18710011 A HU E18710011A HU E055259 T2 HUE055259 T2 HU E055259T2
Authority
HU
Hungary
Prior art keywords
ylcarbamoyl
thiazol
cyano
phenyl
carboxylic acid
Prior art date
Application number
HUE18710011A
Other languages
English (en)
Inventor
Palomino Laria Julio Castro
Gomez Juan Camacho
Original Assignee
Palobiofarma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palobiofarma Sl filed Critical Palobiofarma Sl
Publication of HUE055259T2 publication Critical patent/HUE055259T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE18710011A 2017-03-06 2018-03-06 (1R,3S)-3-(5-ciano-4-fenil-1,3-tiazol-2-il-karbamoil)ciklopentánkarbonsav aminsója HUE055259T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382114 2017-03-06

Publications (1)

Publication Number Publication Date
HUE055259T2 true HUE055259T2 (hu) 2021-11-29

Family

ID=58266535

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18710011A HUE055259T2 (hu) 2017-03-06 2018-03-06 (1R,3S)-3-(5-ciano-4-fenil-1,3-tiazol-2-il-karbamoil)ciklopentánkarbonsav aminsója

Country Status (14)

Country Link
US (1) US10583127B2 (hu)
EP (1) EP3592734B1 (hu)
JP (1) JP6827124B2 (hu)
CY (1) CY1124442T1 (hu)
DK (1) DK3592734T3 (hu)
ES (1) ES2881777T3 (hu)
HR (1) HRP20211104T1 (hu)
HU (1) HUE055259T2 (hu)
LT (1) LT3592734T (hu)
PL (1) PL3592734T3 (hu)
PT (1) PT3592734T (hu)
RS (1) RS62089B1 (hu)
SI (1) SI3592734T1 (hu)
WO (1) WO2018162505A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3882240A1 (en) * 2020-03-16 2021-09-22 Palobiofarma, S.L. Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.

Also Published As

Publication number Publication date
ES2881777T3 (es) 2021-11-30
LT3592734T (lt) 2021-07-26
HRP20211104T1 (hr) 2021-10-15
PT3592734T (pt) 2021-07-21
US10583127B2 (en) 2020-03-10
US20200030300A1 (en) 2020-01-30
SI3592734T1 (sl) 2021-08-31
DK3592734T3 (da) 2021-06-28
EP3592734B1 (en) 2021-05-19
JP6827124B2 (ja) 2021-02-10
EP3592734A1 (en) 2020-01-15
WO2018162505A1 (en) 2018-09-13
CY1124442T1 (el) 2022-07-22
RS62089B1 (sr) 2021-08-31
PL3592734T3 (pl) 2021-11-02
JP2020509066A (ja) 2020-03-26

Similar Documents

Publication Publication Date Title
ZA201808100B (en) Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors
IL280856A (en) 3-Alkyl-4-amino-[0,5,4] bicyclic hydroxamic acids as HDAC inhibitors
EP3145420A4 (en) Intra operative tracking method
PH12017501523A1 (en) Selective bace1 inhibitors
EP3414256A4 (en) AMINO SALT OF OBETICHOLIC ACID
NZ722412A (en) Methods of preparing a hydrochloride salt of (1r,2r,5r)-5-amino-2-methylcyclohexanol
EP3199529A4 (en) Salt of dicarboxylic acid compound
PT3592734T (pt) Sal de amina do ácido (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilcarbamoil)ciclopentano carboxílico
TW201713618A (en) Cyclopropane carboxylic acid amide compound and herbicide containing same
EP3167874A4 (en) Universal cardioplegic solution (variants)
EP3318550A4 (en) Method for preparing benzoic acid amide compound
IL258320B (en) Method for synthesizing n-(1,3,4-oxadiazole-2-yl)aryl carboxamides
EP3205641A4 (en) Aqueous solution containing bis(n -lauroyllysine)dicarboxylic acid diamide and/or salt thereof, and method for producing same
EP3279184A4 (en) Novel benzoic acid amide compound
EP3351530A4 (en) PROCESS FOR PREPARING A SODIUM SALT OF (2,6-DICHLOROPHENYL) AMIDCARBOPENTOXYSULPHANILIC ACID
EP3279199A4 (en) Non-deliquescent acid addition salt of 3-aminoquinuclidine
GB201719127D0 (en) Methylchloroperoxybenzoic acid drug intermediates synthesis method
GB201715085D0 (en) 2-furanacrylic acid drug intermediates synthesis method
GB201715112D0 (en) P-methoxphenylacetic acid drug intermediates synthesis method
GB201714451D0 (en) 3-methoxy-4-hydroxy-5-nitrobenzoic acid drug intermediates synthesis method
GB201709978D0 (en) Drug intermediates p-benzoylbenzoic acid synthesis method
GB201708124D0 (en) Isopropyl myristate drug intermediates myristic acid synthesis method
GB201719123D0 (en) 2,3-dihydroxy-succinic acid drug intermediates synthesis method
GB201714450D0 (en) 4,6-dihydroxyquinoline-5,8-diquinone-2-formic acid drug intermediates synthesis method
GB201705531D0 (en) Pyranzinamide drug intermediates p-diazabenzene-2,3-dicarboxylic acid synthesis method